Cargando…
烟草烟雾通过ROS/Sirt3/SOD2通路诱导NSCLC细胞吉非替尼耐药
Background and objective Epidermal growth factor receptor (EGFR) gene mutations are the most common driver mutations in non-small cell lung cancer (NSCLC). To prolong the survival of the patients, EGFR tyrosine kinase inhibitors (TKIs) resistance in NSCLC is a major challenge that needs to be addres...
Autores principales: | Yawan, ZI, Ke, LIAO, Hong, CHEN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186253/ https://www.ncbi.nlm.nih.gov/pubmed/37183639 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.05 |
Ejemplares similares
-
吉非替尼可能通过EGFR启动子甲基化诱导肺腺癌细胞继发性耐药
Publicado: (2015) -
下调HOTAIR通过提高PTEN表达逆转HCC827细胞吉非替尼耐药
Publicado: (2020) -
TRIM24介导肺癌细胞吉非替尼耐药机制探讨
Publicado: (2016) -
干扰FOXC1逆转非小细胞肺癌吉非替尼耐药的作用
Publicado: (2021) -
肝细胞生长因子诱导敏感非小细胞肺癌细胞对吉非替尼耐药及机制的研究
Publicado: (2013)